Cerapedics

Westminster, United States Founded: 2006 • Age: 20 yrs
Osteobiologic products are developed using synthetic peptide technology.

About Cerapedics

Cerapedics is a Healthcare company based in Westminster (United States) founded in 2006. Osteobiologic products are developed using synthetic peptide technology. Cerapedics has raised $88.46 million across 10 funding rounds from investors including GE Capital, Orbimed and Oxford Finance. The company has 3 employees. Its chief executive, as recorded, is Valeska Schroeder. Its website cerapedics.com draws about 18 thousand monthly visits. Cerapedics offers products and services including i-FACTOR P-15 Peptide Enhanced Bone Graft. Its focus areas include Life Sciences, Regenerative Medicine, Biomaterials and Scaffolds. Its legal entity is CERAPEDICS INC. Its competitors include MiMedx Group, EpiBone and Theradaptive; 2 of its 3 listed competitors have raised funding.

Company details

Cerapedics was founded in 2006 and is headquartered in Westminster, United States. Operations focus on the orthobiologics sector, where proprietary synthetic small peptide technology is developed and commercialized. The iFACTOR Peptide Enhanced Bone Graft is offered as a biologic bone graft that incorporates a small peptide to support natural bone healing. An FDA IDE trial for iFACTOR was completed, meeting all four prespecified primary endpoints.

  • Headquarters Westminster, United States
  • Employees 3
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website cerapedics.com
  • Social LinkedIn X Facebook
  • Legal Name Cerapedics Inc
Key Metrics
  • Total Equity Funding
    $88.46M (USD)

    in 10 rounds

  • Latest Funding Round
    $22M (USD), Series D

    Jul 2018

  • Investors
    GE Capital

    & 5 more

  • Employee Count
    3

Products & Services of Cerapedics

Cerapedics offers a comprehensive portfolio of products and services, including i-FACTOR P-15 Peptide Enhanced Bone Graft.

i-FACTOR P-15 Peptide Enhanced Bone Graft
Bone Graft

FDA-approved product to accelerate bone healing in spine surgery.

Funding Insights of Cerapedics

Cerapedics has successfully raised a total of $88.46M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $22 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $88.46M
  • Total Rounds 10
  • Last Round Series D — $22M
  • First Round $14.46M

    (Sep 2007)

  • Investors Count 6

All 10 funding rounds of Cerapedics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2018$22MSeries D–KCK MedTech
–
Apr 2017$20MDebt – Conventional––
Sep 2016$11MSeries D––
–
Apr 2015$4MDebt – Conventional––
Feb 2015$4MSeries D––
–
Apr 2014$9MDebt – Venture––
Nov 2012$19MSeries C–MedImmune Ventures
Feb 2012$3MSeries B––
–
Mar 2009$15MSeries B–NGN Capital
Sep 2007$14.46MSeries A–Orbimed
–
Valuation history

6 investors in total: 6 institutional.

Investors in Cerapedics

Cerapedics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include GE Capital, Orbimed and Oxford Finance.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
kckmedtech.com
Venture debt firm focused on the life sciences sector
2002oxfordfinance.comAlexandria, United States
medimmuneventures.com
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
1989orbimed.comNew York, United States
NGN Capital is engaged in venture capital investments.
ngncapital.comNew York, United States
Commercial aircraft and equipment leasing and lending services are provided.
1932gecapital.comUnited States
Premium access

Investor details for Cerapedics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Cerapedics

98 people are tracked at Cerapedics (30 in leadership, 7 in board & advisors, 61 in team); the tracked headcount is 3.

NameRoleGroup
Mani Gopal
Chief Operating OfficerLeadership
Valeska Schroeder
CEOLeadership
Holly Smith
Vice President OperationsLeadership
Katherine Lakstins, PhD
Director Medical Affairs/Medical Science LiaisonLeadership
Rebecca Helpert
Director Commercial Operations & ExcellenceLeadership
Alanya M.
Director Of HR And AdministrationLeadership
Caryn Weaver
Senior People Business PartnerLeadership
Lori Hays
Vice President Of RegulatoryLeadership
Avi Aliyu
Senior Director Of AccountingLeadership
Kelley K.
Vice President, Global Commercial Operations & DevelopmentLeadership
Heath Thompson
Senior Director of Strategic Accounts, AmericasLeadership
Tim Benoit-Ledoux
Vice President, Deputy General CounselLeadership
Nathan Philipp
Chief Commercial OfficerLeadership
Thomas Nardi
Associate Vice President FinanceLeadership
Josef Vance
Vp, US Sales OperationsLeadership
Sean L.
Area Vice PresidentLeadership
Jeffrey G. Marx
Chief Scientific OfficerLeadership
Brice Johnson
VP, Human ResourcesLeadership
Shankar Sivshankar
Director Clinical OperationsLeadership
Genevra Enna
Vice President, ControllerLeadership

78 more people are available in the full profile.

Premium access

Complete people profiles for Cerapedics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Cerapedics

3 dated milestones of Cerapedics across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cerapedics is founded.
  2. Funding First funding round of $14.5M.
  3. Funding Latest funding round, Series D, of $22.0M.

Competitors of Cerapedics

Cerapedics has 3 listed competitors in our database, 2 of them funded. They include MiMedx Group, EpiBone and Theradaptive.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
mimedx.com1985Marietta, United States735
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
epibone.com2013Brooklyn, United States$48.63M
Developer of stem cells to regrow damaged bones
theradaptive.com2004Boston, United States$32.2M21
Therapeutic delivery platform is developed for orthopedic clinical indications.
Premium access

Detailed competitors of Cerapedics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Cerapedics

The website of Cerapedics (cerapedics.com) receives about 17.9K visits a month.

  • Monthly visits
    17.9K

    ▼ 44.9% vs previous month

Top companies in Orthopedics

3 companies that operate in the same segment as Cerapedics (Orthopedics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cerapedics

Premium access

Complete news archive for Cerapedics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cerapedics

Cerapedics was founded in 2006 and raised its 1st funding round 1 year after it was founded.

Cerapedics is headquartered in Westminster, United States.

Valeska Schroeder is the CEO of Cerapedics, as recorded in our data.

Cerapedics is a funded company, having raised a total of $88.46M across 10 funding rounds to date. The company's 1st funding round was a Series A of $14.46M, raised on Sep 2007.

Cerapedics has 3 employees.

Cerapedics was founded in 2006 and is headquartered in Westminster, United States. Operations focus on the orthobiologics sector, where proprietary synthetic small peptide technology is developed and commercialized. The iFACTOR Peptide Enhanced Bone Graft is offered as a biologic bone graft that incorporates a small peptide to support natural bone healing. An FDA IDE trial for iFACTOR was completed, meeting all four prespecified primary endpoints.

Cerapedics's top competitors include EpiBone, Theradaptive and MiMedx Group.

Cerapedics offers i-FACTOR P-15 Peptide Enhanced Bone Graft.

Cerapedics has 6 investors. Key investors include GE Capital, Orbimed, Oxford Finance, KCK MedTech, and MedImmune Ventures.

Cerapedics operates through Cerapedics Inc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available